Inventor
POWERS JAY PATRICK
US37 patents
⚠️ This page may combine multiple inventors who share the name “POWERS JAY PATRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARCUS BIOSCIENCES INC
22 patentsUS11001603B2May 11, 2021
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC13 citations93
US10239912B2Mar 26, 2019
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC23 citations93
US10981944B2Apr 20, 2021
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC11 citations84
US11667662B2Jun 6, 2023
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC4 citations83
US11633416B1Apr 25, 2023
Oral formulations of CD73 compounds
ARCUS BIOSCIENCES INC4 citations73
US11058704B2Jul 13, 2021
Inhibitors of adenosine 5′-nucleotidase
ARCUS BIOSCIENCES INC4 citations71
US11787762B2Oct 17, 2023
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC2 citations69
US11407712B2Aug 9, 2022
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
ARCUS BIOSCIENCES INC3 citations69
US12168023B2Dec 17, 2024
Inhibitors of adenosine 5′-nucleotidase
ARCUS BIOSCIENCES INC1 citations61
US11993584B2May 28, 2024
Solid forms of an azolopyrimidine compound
ARCUS BIOSCIENCES INC0 citations61
US11267845B2Mar 8, 2022
Inhibitors of CD73-mediated immunosuppression
ARCUS BIOSCIENCES INC1 citations61
US11045472B2Jun 29, 2021
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations61
US12459967B2Nov 4, 2025
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC0 citations60
US12103907B2Oct 1, 2024
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC0 citations59
US12433836B2Oct 7, 2025
Parenterally administered immune enhancing drugs
ARCUS BIOSCIENCES INC0 citations56
US12195482B1Jan 14, 2025
Compounds as inhibitors of AXL
ARCUS BIOSCIENCES INC0 citations55
US11220492B2Jan 11, 2022
Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC0 citations51
US12410170B2Sep 9, 2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds
ARCUS BIOSCIENCES INC0 citations48
US11931343B2Mar 19, 2024
CD73 inhibitors
ARCUS BIOSCIENCES INC0 citations48
US12226425B2Feb 18, 2025
Inhibitors of ARG1 and/or ARG2
ARCUS BIOSCIENCES INC0 citations47
US12071411B2Aug 27, 2024
Inhibitors of HIF-2α and methods of use thereof
ARCUS BIOSCIENCES INC0 citations47
US12064433B2Aug 20, 2024
Pyridone A2R antagonists
ARCUS BIOSCIENCES INC0 citations47
FLEXUS BIOSCIENCES INC
8 patentsUS9598422B2Mar 21, 2017
Immunoregulatory agents
FLEXUS BIOSCIENCES INC21 citations93
US9643972B2May 9, 2017
Immunoregulatory agents
FLEXUS BIOSCIENCES INC15 citations91
US10106546B2Oct 23, 2018
Immunoregulatory agents
FLEXUS BIOSCIENCES INC6 citations83
US10533014B2Jan 14, 2020
Immunoregulatory agents
FLEXUS BIOSCIENCES INC3 citations72
US11932601B2Mar 19, 2024
Immunoregulatory agents
FLEXUS BIOSCIENCES INC0 citations61
US11242319B2Feb 8, 2022
Immunoregulatory agents
FLEXUS BIOSCIENCES INC0 citations61
US10206893B2Feb 19, 2019
Immunoregulatory agents
FLEXUS BIOSCIENCES INC0 citations51
US10987322B2Apr 27, 2021
Immunoregulatory agents
FLEXUS BIOSCIENCES INC0 citations50
BRISTOL MYERS SQUIBB CO
4 patentsUS12421195B2Sep 23, 2025
Amorphous and crystalline forms of IDO inhibitors
BRISTOL MYERS SQUIBB CO0 citations60
US11236049B2Feb 1, 2022
Amorphous and crystalline forms of IDO inhibitors
BRISTOL MYERS SQUIBB CO0 citations60
US11919863B2Mar 5, 2024
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
BRISTOL MYERS SQUIBB CO0 citations56
US11236048B2Feb 1, 2022
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
BRISTOL MYERS SQUIBB CO0 citations56